Cerebellum’s Encompass Health EHC Stock Holding History

Cerebellum’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$64K	Sell	1,232 -2,058	-63%	-$106K	0.3%	125
2020 Q2	$129K	Buy	+3,290	New	+$178K	0.09%	141
2019 Q4	$523K	Buy	9,497 +497	+6%	+$27K	0.28%	270
2019 Q3	$453K	Buy	9,000 +1,985	+28%	+$99.7K	0.29%	65
2019 Q2	$354K	Buy	7,015 +201	+3%	+$9.76K	0.29%	97
2019 Q1	$317K	Buy	6,814 +4,790	+237%	+$243K	0.28%	263
2018 Q4	$99K	Sell	2,024 -1,020	-34%	-$58K	0.07%	379
2018 Q3	$189K	Buy	+3,044	New	+$185K	0.3%	59
2018 Q2	–	Sell	-4,182	Closed	-$190K	–	443
2018 Q1	$190K	Buy	4,182 +892	+27%	+$38.2K	0.24%	109
2017 Q4	$129K	Buy	+3,290	New	+$125K	0.09%	141

Other funds holding EHC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Cerebellum's EHC Position: Q3 2020 in Review

Cerebellum reduced its Encompass Health (EHC) stake by 63% in Q3 2020, selling an estimated $106K and leaving 1,232 shares worth $64K. The position accounts for 0.3% of the portfolio, ranked #125.

Cerebellum first reported a position in EHC in Q4 2017 and has held it in 10 quarters since. The position peaked at $523K in Q4 2019. 380 funds tracked by Wall St. Rank hold EHC as of Q3 2020.

Cerebellum held 1,232 shares of Encompass Health worth $64K as of Q3 2020.
Cerebellum sold 2,058 Encompass Health shares in Q3 2020, an estimated $106K.
Encompass Health made up 0.3% of Cerebellum's portfolio in Q3 2020, its #125 holding.
Cerebellum first reported a position in Encompass Health in Q4 2017 and has held it in 10 quarters since.
Cerebellum's Encompass Health position peaked at $523K in Q4 2019.
380 funds tracked by Wall St. Rank held Encompass Health as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.